Form 4: BioNexus Gene Lab CFO Receives Stock Grant
Insider Transaction (Form 4)
Set Fui Chong, Chief Financial Officer of BioNexus Gene Lab Corp, received 96,774 shares of common stock on August 13, 2026.
Summary
- Grant/award: acquired 96,774 Common Shares on August 13, 2026; holds 96,774 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Set Fui Chong — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Grant/award | Common Shares | 96,774 | — | — | 96,774 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Grant/award (96,774 shares) |
Keywords
insider transaction, Form 4, BGLC, BioNexus Gene Lab Corp, neutral, Set Fui Chong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.